A large company specializing in mail order prescription fulfillment is facing a time and attendance lawsuit in the state of Arizona, according to Digital Journal. The suit has been classified under class-action status and was filed in the U.S. District Court for the District of Arizona.
The case centers on employees who performed work as coders for the company, but were classified under an exempt status that denied them overtime when working more than the 40 hours in a standard week. Under the Fair Labor Standards Act, individuals who fall under the "Computer Employee Exemption" status are not allowed to receive overtime pay.
"Just because an employee works in an office at a computer doesn't mean that they aren't entitled to overtime pay when they work long hours," Tim C. Selander, an attorney at the Nichols Kaster law firm representing the plaintiff in this case, said in a recent press release.
In the suit, the plaintiff, and any other employees who currently work in a similar capacity are looking to be compensated for any overtime hours that went unpaid, as well as other compensatory damages.
All data and information provided on this news blog is for informational purposes only. Infinisource makes no representations as to accuracy, completeness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. Information regarding employment suits and other legal action is not updated after publication, and may not be current.
A drug store chain recently agreed to a $23 million class-action settlement and learned some expensive lessons about the FLSA and state wage-and-hour laws.
90 people employed by the company, either in the field as equipment operators or in other support roles, claim they routinely worked between 50 and 100 hours per week without being compensated for overtime.
Drug testing lab Cetero Research recently offered assurances following an announcement by the United States Food and Drug Administration regarding the deliberate misreporting of dates by chemists seeking to falsify their employee attendance records.